comparemela.com

Page 8 - Peijia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Peijia Medical Obtained Exclusive License for JenaValve s Trilogy TAVR System for Treating AR in the Greater China Region

/PRNewswire/ Peijia Medical Limited (HKEX: 9996) is pleased to announce its strategic investment and exclusive in-licensing agreement with JenaValve.

United statesHong kongYi zhangJohn kilcoyneGimv euronextBain capital life sciencesDrug administrationPeijia medical limitedJenavalve technology incPeijia medicalPrnewswire peijia medical limitedHong kong stock exchangeValiance life sciencesMedical limitedJenavalve technologyGreater china

First Successful Clinical Mitral Valve Replacement

On December 22, 2021, the first clinical case using HighLife transseptal mitral valve replacement (TSMVR) technology was successfully carried out in Asia. The implantation of Peijia's Highlife TSMVR system was performed by Professor Mao Chen and his team of West China Medical Center of Sichuan University as part of a research clinical trial. - Click here if this is your press release! - eTurboNews | Trends | Travel News

Mao chenCity ofUnited kingdomNicolo piazzaJean buithieuMichael zhang yiMcgill university medical centerProfessor maoMitral valve replacementPeijia medicalGreater chinaProfessor nicolo piazzaProfessor jean buithieuProfessor mao chenHighlife system

Peijia Medical s New Milestone Asia s first successful clinical case using HighLife transseptal mitral valve replacement technology

/PRNewswire/ On December 22, 2021, the first clinical case using HighLife transseptal mitral valve replacement ("TSMVR") technology was successfully carried.

Mao chenCity ofUnited kingdomNicolo piazzaJean buithieuMichael zhang yiMcgill university medical centerPeijia medicalMitral valve replacementGreater chinaProfessor nicolo piazzaProfessor jean buithieuProfessor mao chenHighlife systemPeijia medical limited

Peijia Medical s New Milestone Asia s first successful clinical case using HighLife transseptal mitral valve replacement technology

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Mao chenCity ofUnited kingdomNicolo piazzaJean buithieuMichael zhang yiMcgill university medical centerChina medical centerSichuan universityPeijia medicalProfessor mao chenWest china medical centerProfessor maoMitral valve replacementGreater chinaProfessor nicolo piazza

Peijia Medical s New Milestone Asia s first successful clinical case using HighLife transseptal mitral valve replacement technology

/PRNewswire/ On December 22, 2021, the first clinical case using HighLife transseptal mitral valve replacement ("TSMVR") technology was successfully carried.

Mao chenCity ofUnited kingdomNicolo piazzaJean buithieuMichael zhang yiMcgill university medical centerPeijia medicalMitral valve replacementGreater chinaProfessor nicolo piazzaProfessor jean buithieuProfessor mao chenHighlife systemPeijia medical limited

vimarsana © 2020. All Rights Reserved.